Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates - Wikidata - awgldk - TriplyDB

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates

http://www.wikidata.org/entity/Q33832168

about

New viruses for cancer therapy: meeting clinical needs Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer Understanding and altering cell tropism of vesicular stomatitis virus Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS.Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.Oncolytic viruses: From bench to bedside with a focus on safety.In vivo delivery of cytoplasmic RNA virus-derived miRNAs.Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.Curative one-shot systemic virotherapy in murine myeloma.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy.Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV.Ablation of nectin4 binding compromises CD46 usage by a hybrid vesicular stomatitis virus/measles virus.Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer.Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.Oncolytic vaccines.Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer.Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model.Oncolytic Immunotherapy for Treatment of Cancer.Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model.VSV based virotherapy in ovarian cancer: the past, the present and …future?Highly attenuated recombinant vesicular stomatitis virus VSV-12'GFP displays immunogenic and oncolytic activity Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Review: Oncolytic virotherapy, updates and future directions.The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies.Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.Oncolytic virotherapy in upper gastrointestinal tract cancers.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.

P2860

Q24567699-7AFDD695-E7C9-4337-B52F-A5AF06B42A67 Q27021839-85B69846-52E7-41E1-98F9-002CB25BC0EC Q27687067-A9E88F0F-D075-4105-A147-75A2F84C3808 Q28078939-C0300939-8993-44FD-B64A-8F04F86943BE Q33434692-2A6ED4C4-6F11-4EA8-B25C-6A0D99E7E5BA Q33579385-8F77A56B-93BC-483B-B20A-1C37ED8E2C15 Q34013572-633B2151-2CEF-4062-BE16-4BE6F4D0238C Q34044071-0289A537-68AA-4CA7-9BE4-868F27F59BD9 Q35750036-A4F1E21A-9614-40FD-AEAC-1FCB1C825593 Q35861186-009413D2-B6A8-4DDB-A65B-825A6A7532BD Q35893563-62E1B4AD-873F-4133-A66F-DDF4C5913FD9 Q35988675-048130BD-32DE-4BA4-A49F-A78CCFAF2D11 Q36049446-770AC8E8-F877-46A2-9D12-8E41174FCA4E Q36139716-60556629-6327-424A-B0FD-E4FAAF9E7824 Q36751597-FD9AA0EC-8B71-47BE-8B6D-B936B6A74A20 Q37100179-53BA39E1-2398-4EA6-BB08-2112979D5A30 Q37373616-8BF02589-13AA-4F82-8494-D413F920455E Q37547082-52A39FE2-F95C-4A2E-BEBE-5A343933253E Q37625385-ECC8BA37-2351-4F37-9F2A-1E203E9903F8 Q37672599-0B7E54F0-3D33-4EDD-B47A-532CFE7ED050 Q37714030-36A74C6B-7493-4461-A32C-E6C122D00CA1 Q38152474-9E8DEA4A-C359-45E5-9261-F8DC00B87E68 Q38261256-94A80F16-7C58-47E5-B216-222C99805DE2 Q38734741-D2B1A8FB-030A-46F7-A4E8-DA7B93B823BE Q38848223-E4327D0A-28EB-4E0B-B1A3-E5BD0F149132 Q39096636-CB588D43-FBDA-4ECC-A4D2-BE9403555535 Q39127778-D36D912A-D39B-4EFB-9F06-3ED4EFEBE41E Q39600108-106C8A66-B62F-4002-8541-9BF8E2A7CBD6 Q41441101-DF71E6D4-C2CE-45B0-A8F5-72297C257732 Q41770092-C4DA9196-7A07-43AA-AA1A-91F0E69D0465 Q45324769-4EA9DB33-83FF-462A-950D-909E6A76F57D Q47160989-A57E948E-1DDB-49DA-9D28-B46517E56EA3 Q52769266-8FA77BAB-AFB4-44B1-8CD7-448C36C5B4FC Q54202657-88FA57AF-41E9-4015-853F-A563C2A3605B Q54242367-98332598-5D21-447C-8EB5-5B22EE24B90A Q54378300-F0EA4A69-EFBD-475F-A22C-A9300D3F77B4 Q55652233-DE746A6B-1F56-4DF6-B3CB-CA36157EAF35

P2860

Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates

http://www.wikidata.org/entity/Q33832168

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Safety studies on intrahepatic ...... rodents and nonhuman primates

@ast

Safety studies on intrahepatic ...... rodents and nonhuman primates

@en

type

label

Safety studies on intrahepatic ...... rodents and nonhuman primates

@ast

Safety studies on intrahepatic ...... rodents and nonhuman primates

@en

prefLabel

Safety studies on intrahepatic ...... rodents and nonhuman primates

@ast

Safety studies on intrahepatic ...... rodents and nonhuman primates

@en

P1433

Q33832168-25F9D4BA-99F2-4D3A-9D36-DB1A3F95370D

P1476

Q33832168-5B44A7F6-A2B4-452C-BBAA-8346E2CA54EF

P2093

Q33832168-0AB1BD19-C3B3-47C4-B5A5-8410F7C7BACE

Q33832168-1FE4FF12-4E26-4A62-B407-8D0B0C4C8CD3

Q33832168-28632BBB-E9F8-4269-BEF8-AC7C4A39168F

Q33832168-38260FE6-C180-4024-A8D0-E6DC45EEAD28

Q33832168-39EB82C3-65BB-4324-809B-DCDF33F91BF0

Q33832168-3B45BA16-04BE-4976-9BC4-3F0C0D30BEAF

Q33832168-4290E059-79BA-4AD7-BE00-39647DE34A6B

Q33832168-8B235426-CFE0-427B-8F2C-0E25A9293564

Q33832168-92A7CCF0-CE72-4665-A126-989F567BA82A

Q33832168-A15443F8-5AE8-46FD-ABBE-6D43B23EFE62

P2860

Q33832168-0C11C678-3B07-4CC7-B789-0C3E9EDFB8A6

Q33832168-20E04CBE-A42E-4CEB-9ABF-933949AC7E80

Q33832168-22DF7463-071A-45B3-854C-AEBDAA83FD1F

Q33832168-35AF1D2E-4286-44B8-9B39-73BCF9802A4A

Q33832168-4FF178E8-0587-4EF9-B87E-476BA82FB04B

Q33832168-55833F4E-05C3-49F0-94C6-40C5938BD9E6

Q33832168-5CD8387D-5E55-4622-9E4F-B270FE07BC78

Q33832168-646A3AB8-3DB7-4EB9-AE3F-D342BF9E5FD4

Q33832168-667952E7-4216-4760-98FC-42A030D59497

Q33832168-6B263F56-CCCC-43E9-BADC-DDE73BF93F5D

P304

Q33832168-18E3E13F-5CF7-40BC-BDDC-B5165BA331AA

P31

Q33832168-8D97F11D-885D-4603-930F-1F7831F52FF1

P356

Q33832168-4228353D-AA62-4036-AF6E-6AD627BC3751

P433

Q33832168-D6A73437-F595-4886-8ED8-3B00CCEC10D7

P478

Q33832168-58B3C5C1-4556-4B1C-B5FD-C3420E20B8D8

P50

Q33832168-C17C87AA-24EB-461B-B649-D71DFC67AAF5

Q33832168-D4E675EC-6F45-4ACE-BFDC-3937530E1D55

P577

Q33832168-97464E6F-7277-4BDC-AA61-6197B4DD0CE7

P5875

Q33832168-3706465B-20A0-471D-8971-6610097D5782

P698

Q33832168-B37BEC3C-4EE2-4DC3-8507-77D379FFBFCF

P921

Q33832168-C0FF9071-15F9-49D3-A624-A3B550C43264

P932

Q33832168-3E05849F-675A-4CB1-A8D7-BC92F5B58A32

P356

P1433

Human Gene Therapy

P1476

Safety studies on intrahepatic ...... rodents and nonhuman primates

@en

P2093

Andrew Greenslade

http://www.w3.org/2001/XMLSchema#string

Emily K Mader

http://www.w3.org/2001/XMLSchema#string

Glen N Barber

http://www.w3.org/2001/XMLSchema#string

Guy E Griesmann

http://www.w3.org/2001/XMLSchema#string

Jill Thompson

http://www.w3.org/2001/XMLSchema#string

Jorge Rakela

http://www.w3.org/2001/XMLSchema#string

Mark J Federspiel

http://www.w3.org/2001/XMLSchema#string

Michael C Blanco

http://www.w3.org/2001/XMLSchema#string

Mitesh J Borad

http://www.w3.org/2001/XMLSchema#string

Nathan Jenks

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Sorafenib in advanced hepatocellular carcinoma

Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma.

Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

VSV-tumor selective replication and protein translation.

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.

Vesicular stomatitis virus: re-inventing the bullet.

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates

Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.

P304

451-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2009.111

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J Russell

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38088006

http://www.w3.org/2001/XMLSchema#string

P698

19911974

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2865219

http://www.w3.org/2001/XMLSchema#string